Citation Impact
Citing Papers
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
2002 StandoutScience
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
2000
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Molecular cloning and characterization of the rat NMDA receptor
1991 StandoutNature
NMDA receptor antagonists can enhance or impair learning performance in animals
1989
The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests
1994
Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine
1996
Effect of rapamycin on aging and age-related diseases—past and future
2020
Modulation of learning and memory by natural polyamines
2016
(+)‐WAY 100135, a partial agonist, at native and recombinant 5‐HT1B/1D receptors
1997
Implication of Poly(ADP‐Ribose) Polymerase (PARP) in Neurodegeneration and Brain Energy Metabolism: Decreases in Mouse Brain NAD+ and ATP Caused by MPTP Are Prevented by the PARP Inhibitor Benzamide
1999
Zolmitriptan stimulates a Ca2+-dependent K+ current in C6 glioma cells stably expressing recombinant human 5-HT1B receptors
2000
MK-801-induced stereotypy and its antagonism by neuroleptic drugs
1990
Descending control of pain
2002 Standout
Testing the NMDA, Long-term Potentiation, and Cholinergic Hypotheses of Spatial Learning
1998
WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid
1997
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
1992
5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions
1993
Pretraining and the Function of Hippocampal Long-Term Potentiation
2000 StandoutNobel
Hallmarks of aging: An expanding universe
2023 Standout
Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse
1994
The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor
1989
Synthesis and evaluation of antifungal properties of a series of the novel 2-amino-5-oxo-4-phenyl-5,6,7,8-tetrahydroquinoline-3-carbonitrile and its analogues
2007
Molecular and cellular mechanisms of general anaesthesia
1994 StandoutNature
Ethanol and neurotransmitter interactions—from molecular to integrative effects
1998
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations
1992
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 Standout
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
1995
Mitochondrial DNA, base excision repair and neurodegeneration
2008
Noncompetitive excitatory amino acid receptor antagonists
1990
Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: Effect of 5,7-dihydroxytryptamine
1997
Frequency of gamma oscillations routes flow of information in the hippocampus
2009 StandoutNatureNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
DNA Damage, Aging, and Cancer
2009 Standout
The Serotonin Syndrome
2005 Standout
Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome
2001
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999
Migraine — Current Understanding and Treatment
2002 Standout
A review of central 5-HT receptors and their function
1999 Standout
Major Depressive Disorder
2008 Standout
The noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits
1989
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs
1993
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
1995
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
1989 StandoutNobel
Alzheimer's Disease
2004 Standout
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
2005 StandoutNature
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy
1999
Detailed behavioral analysis of water maze acquisition under APV or CNQX: Contribution of sensorimotor disturbances to drug-induced acquisition deficits.
1996
Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5‐HT1A autoreceptor in vivo
1998
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade
2004
Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats
1993
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
2007 Standout
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Antibody-Mediated Encephalitis
2018 Standout
Donitriptan, a Unique High‐Efficacy 5‐HT1B/1DAgonist: Key Features and Acute Antimigraine Potential
2000
Bond Formations between Two Nucleophiles: Transition Metal Catalyzed Oxidative Cross-Coupling Reactions
2011 Standout
Synthesis of β- and γ-Carbolines by the Palladium-Catalyzed Iminoannulation of Alkynes
2002
Pretraining Prevents Spatial Learning Impairment after Saturation of Hippocampal Long-Term Potentiation
1999 StandoutNobel
Why NMDA-receptor-dependent long-term potentiation may not be a mechanism of learning and memory: Reappraisal of the NMDA-receptor blockade strategy
1990
Anatomic correlation of NMDA and 3H-TCP-labeled receptors in rat brain
1988
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
1996 Standout
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
1991 Standout
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Impaired Long-Term Potentiation, Spatial Learning, and Hippocampal Development in fyn Mutant Mice
1992 StandoutScienceNobel
De novo synthesis of substituted pyridines
2004 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
The structural landscape of heteroaryl-2-imidazoles: competing halogen- and hydrogen-bond interactions
2014
Cerebral hypoxia: some new approaches and unanswered questions
1990
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Ethanol-Induced Apoptotic Neurodegeneration and Fetal Alcohol Syndrome
2000 StandoutScience
An Orally Active Selenium-Based Antihypertensive Agent with Restricted CNS Permeability
1997
Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors.
1992 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Indatraline: Synthesis and Effect on the Motor Activity of Wistar Rats
2011
Ethanol Inhibits NMDA-Activated Ion Current in Hippocampal Neurons
1989 Science
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
1999 StandoutScience
Non-competitive antagonists of excitatory amino acid receptors
1987
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Systemic approaches to modifying quinolinic acid striatal lesions in rats
1988
Serotonin Receptors
2008
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors
1989
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Regioselective Functionalization of the Imidazole Ring via Transition Metal‐Catalyzed CN and CC Bond Forming Reactions
2010
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
A highly efficient regioselective one-pot synthesis of 2,3,6-trisubstituted pyridines and 2,7,7-trisubstituted tetrahydroquinolin-5-ones using K5CoW12O40·3H2O as a heterogeneous recyclable catalyst
2007
Neuroscience: Breaking Down Scientific Barriers to the Study of Brain and Mind
2000 StandoutScienceNobel
Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines
2000
The Halogen Bond
2016 Standout
Parallel Instabilities of Long-Term Potentiation, Place Cells, and Learning Caused by Decreased Protein Kinase A Activity
2000 StandoutNobel
Transition-Metal-Catalyzed Reactions in Heterocyclic Synthesis
2004 Standout
Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities
1999
Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D- aspartate receptor antagonist AP5
1989
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
Recent advances in the phencyclidine model of schizophrenia
1991 Standout
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Synaptic Plasticity and Memory: An Evaluation of the Hypothesis
2000 Standout
Rewarding Actions of Phencyclidine and Related Drugs in Nucleus Accumbens Shell and Frontal Cortex
1996
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Retrograde Amnesia for Spatial Memory Induced by NMDA Receptor-Mediated Long-Term Potentiation
2001 StandoutNobel
Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes
1992 StandoutScienceNobel
Works of Wouter Koek being referenced
MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
1988
Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.
1996
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
1989
Pharmacological Characterization of In Vivo Properties of Putative Mixed 5-HT1AAgonist/5-HT2A/2C Antagonist Anxiolytics. II. Drug Discrimination and Behavioral Observation Studies in Rats
1997
F 11356, a Novel 5-Hydroxytryptamine (5-HT) Derivative with Potent, Selective, and Unique High Intrinsic Activity at 5-HT1B/1D Receptors in Models Relevant to Migraine
1999
5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy
2002
Pharmacological characterization of the discriminative stimulus properties of the phencyclidine analog, N -[1-(2-benzo(b)thiophenyl)-cyclohexyl]piperidine
1999
In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia
2001
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
2018
Behavioral pharmacology of antagonists at 5-HT2/5-HT1C receptors
1992
l-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine
1989
Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans
1999
Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: Structure-activity studies☆
1987
Possiblein vivo5‐HT reuptake blocking properties of 8‐OH‐DPAT assessed by measuring hippocampal extracellular 5‐HT using microdialysis in rats
1996
NMDA antagonists make learning and recall state-dependent
1992
(−)-Pindolol and (±)-Tertatolol Affect Rat Hippocampal 5-HT Levels Through Mechanisms Involving Not Only 5-HT1A, But Also 5-HT1B Receptors
1996
Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence
1995
Design and Synthesis of a Series of 6-Substituted-2-pyridinylmethylamine Derivatives as Novel, High-Affinity, Selective Agonists at 5-HT1AReceptors
1998
Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate
1986
S 14506: A novel, potent, high‐efficacy 5‐HT1A agonist and potential anxiolytic agent
1992
F 11440, a Potent, Selective, High Efficacy 5-HT1AReceptor Agonist with Marked Anxiolytic and Antidepressant Potential
1998
Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.
1990
N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
1990
Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties
1996
Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice
1996
Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors
1999
Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate
1986
A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats
1987
BEHAVIOURAL PHARMACOLOGY OF NMDA RECEPTOR ANTAGONISTS
1995
Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and Vogel conflict procedures
1990